Strategic National Stockpile | Global Biodefense

Menu

Latest stories

Illustrative representation of MRSA - Antibiotic Resistance

In Fight Against Superbugs, BARDA Looks to Shore Up National Stockpile Countermeasures

US Invests Additional 44 Million in Smallpox Vaccine Manufacturing

More on pathogens and preparedness

BARDA Industry Day 2019

by Global Biodefense October 15, 2019, 12:00 am
SIGA, USAMRIID Enter Agreement to Evaluate Post-Exposure Prophylactic for Smallpox

by Global Biodefense October 4, 2018, 3:30 am
CDC to Award Contract to Emergent for 9 Million Doses of Smallpox Vaccine
FBI Seeks Tamiflu Supplier for Pandemic Flu Preparedness Program

by Global Biodefense July 12, 2018, 7:58 am
Health and Human Services Biodefense Budget Oversight

by Stephanie Lizotte April 29, 2018, 10:37 am
Project BioShield: HHS Purchases Anthrax Countermeasure from Elusys Therapeutics

by Global Biodefense April 23, 2018, 3:55 pm
U.S. Seeks to Develop Late-Stage Smallpox Antivirals
Bavarian Nordic Highlights Smallpox Orders, Vaccine Development

by Global Biodefense November 10, 2017, 8:40 am
First Shipment of ANTHIM Anthrax Treatment Delivered to Strategic National Stockpile

by Global Biodefense October 10, 2017, 4:04 pm
Biodefense Headlines – October 1, 2017

by Stephanie Lizotte October 1, 2017, 3:16 pm
Emergent BioSolutions to Acquire Smallpox Vaccine Business from Sanofi
CDC Stockpile Trainer Helps Other Countries Improve Supply Chain Preparedness

by Global Biodefense February 28, 2017, 2:31 pm

Congratulations. You've reached the end of the internet.

Back to Top